FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments

FRIDAY, July 24, 2026— A panel of outside advisers to the U.S. Food and Drug Administration (FDA) voted Thursday to let specialized pharmacies produce and sell four peptide treatments the agency banned three years ago.The votes are nonbinding, but...